185 related articles for article (PubMed ID: 17483309)
1. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
Tesfaye A; Di Cello F; Hillion J; Ronnett BM; Elbahloul O; Ashfaq R; Dhara S; Prochownik E; Tworkoski K; Reeves R; Roden R; Ellenson LH; Huso DL; Resar LM
Cancer Res; 2007 May; 67(9):3998-4004. PubMed ID: 17483309
[TBL] [Abstract][Full Text] [Related]
2. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts.
Di Cello F; Hillion J; Kowalski J; Ronnett BM; Aderinto A; Huso DL; Resar LM
Mol Cancer Ther; 2008 Jul; 7(7):2090-5. PubMed ID: 18645019
[TBL] [Abstract][Full Text] [Related]
4. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
5. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic properties of the HMG-I gene family.
Wood LJ; Maher JF; Bunton TE; Resar LM
Cancer Res; 2000 Aug; 60(15):4256-61. PubMed ID: 10945639
[TBL] [Abstract][Full Text] [Related]
8. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.
Xu Y; Sumter TF; Bhattacharya R; Tesfaye A; Fuchs EJ; Wood LJ; Huso DL; Resar LM
Cancer Res; 2004 May; 64(10):3371-5. PubMed ID: 15150086
[TBL] [Abstract][Full Text] [Related]
9. The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.
Swisher EM; Gown AM; Skelly M; Ek M; Tamimi HK; Cain JM; Greer BE; Muntz HG; Goff BA
Gynecol Oncol; 1996 Jan; 60(1):81-8. PubMed ID: 8557233
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
[TBL] [Abstract][Full Text] [Related]
11. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.
Müller-Decker K; Fürstenberger G; Annan N; Kucher D; Pohl-Arnold A; Steinbauer B; Esposito I; Chiblak S; Friess H; Schirmacher P; Berger I
Gastroenterology; 2006 Jun; 130(7):2165-78. PubMed ID: 16762637
[TBL] [Abstract][Full Text] [Related]
12. Increased cyclooxygenase-2 expression associated with inflammatory cellular infiltration in elderly patients with vulvar cancer.
Lee TS; Jeon YT; Kim JW; Won JK; Park NH; Park IA; Juhnn YS; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():143-53. PubMed ID: 17404027
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis.
Matsumura N; Mandai M; Miyanishi M; Fukuhara K; Baba T; Higuchi T; Kariya M; Takakura K; Fujii S
Clin Cancer Res; 2006 Mar; 12(5):1402-11. PubMed ID: 16533762
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells.
Chan MW; Wong CY; Cheng AS; Chan VY; Chan KK; To KF; Chan FK; Sung JJ; Leung WK
Oncol Rep; 2007 Dec; 18(6):1557-62. PubMed ID: 17982644
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A
Oncogene; 2005 May; 24(21):3427-35. PubMed ID: 15735694
[TBL] [Abstract][Full Text] [Related]
16. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms.
Subramaniam D; Ramalingam S; May R; Dieckgraefe BK; Berg DE; Pothoulakis C; Houchen CW; Wang TC; Anant S
Gastroenterology; 2008 Apr; 134(4):1070-82. PubMed ID: 18395088
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation.
Pandey M; Prakash O; Santhi WS; Soumithran CS; Pillai RM
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):379-83. PubMed ID: 18356024
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
Furuta E; Pai SK; Zhan R; Bandyopadhyay S; Watabe M; Mo YY; Hirota S; Hosobe S; Tsukada T; Miura K; Kamada S; Saito K; Iiizumi M; Liu W; Ericsson J; Watabe K
Cancer Res; 2008 Feb; 68(4):1003-11. PubMed ID: 18281474
[TBL] [Abstract][Full Text] [Related]
20. 6p21 rearrangements in uterine leiomyomas targeting HMGA1.
Nezhad MH; Drieschner N; Helms S; Meyer A; Tadayyon M; Klemke M; Belge G; Bartnitzke S; Burchardt K; Frantzen C; Schmidt EH; Bullerdiek J
Cancer Genet Cytogenet; 2010 Dec; 203(2):247-52. PubMed ID: 21156240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
